VIDEO - Future is bio-pharma: Kiran Mazumdar-Shaw
Biocon's executive chairperson Dr Kiran Mazumdar Shaw, calls for a PLI scheme specially focused on incentivising biopharma investment.
Biocon's executive chairperson Dr Kiran Mazumdar Shaw, calls for a PLI scheme specially focused on incentivising biopharma investment.
Syngene International was started by Biocon in 1993 to provide research services for pharma companies. Three decades later, the entity wants to become a global science company in its own right.
Its net profit rose by 2% to Rs 130 crore from Rs 127 crore a year ago, representing a net profit margin of 11%.